Phillip A. Sharp - Director, Alnylam Pharmaceuticals, Inc

As of July 2, 2019


Phillip A. Sharp Net Worth

  • Net worth is estimated to be at least $287.31M
  • Owns at least 266,899 units of Alnylam Pharmaceuticals, Inc stock
  • Sold an estimated value of $20.25M in the last 15 years at Alnylam Pharmaceuticals, Inc

Phillip A. Sharp Trading

  • Largest purchase of shares was 131,890 units , worth over $847.8K on October 15, 2014
  • Largest sale of shares was 131,890 units , worth over $9.35M on October 15, 2014
  • In total has made about 28 transactions over 15 years
  • Usually trades in June, with the busiest year in 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Phillip A. Sharp Mailing Address

  • Mailing address is Biogen Inc Legal Department 14 Cambridge Center Cambridge MA 02142 MA

Alnylam Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 15,000 units sold on April 5, 2022 by Steven M Paul worth over $2.56M
  • In the last 18 years, insiders at Alnylam Pharmaceuticals, Inc sold an estimated value of $488.87M and bought an estimated value of $246.16M
  • The most active traders are John Maraganore, Chief Executive Officer,  Akshay Vaishnaw, President,  and Barry E Greene, President
  • Insider trading is most common in June, with the busiest year in 2014

POLARIS INDUSTRIES INC/MN Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1